Research News and Research

RSS

FDA grants clearance for HPβCD treatment for Niemann Pick Type C disease

Children's Hospital & Research Center Oakland announced today that the US Food and Drug Administration (FDA) has granted clearance of an Investigational New Drug (IND) application to introduce Trappsol Cyclo (Hydroxypropyl Beta Cyclodextrin or HPβCD) into the brains of six year old identical twin girls dying of a rare brain-destroying cholesterol disease called Niemann Pick Type C (NPC).

24 Sep 2010

Breast cancer incidence drops, linked to decline in HRT use

A new Canadian study shows that a significant drop in breast cancer incidence among post-menopausal women from 2002 to 2004 coincided with a sharp drop in hormone replacement therapy (HRT) use during the same period. This is the first study to show the link between HRT use and breast cancer among Canadian women.

24 Sep 2010

Health Reform's Big Day: New consumer protections start now

Today marks the six month anniversary of enactment of the health reform law, and with it, a slew of consumer friendly provisions go into effect.

24 Sep 2010

Advanced Targeting Systems receives NCI award to advance SP-SAP drug

Advanced Targeting Systems, the company that pioneered the targeting of specific cell types to manipulate them for the treatment of diseases and for research into the function of biological systems, has been awarded $3 million from the National Cancer Institute (NCI).

24 Sep 2010

General Electric Co. announces plans to donate $50 million to community health clinics

General Electric Co plans to donate about $50 million to community health clinics across the United States over the next couple of years, saying that urban clinics can play a role in the effort to slow the rapid rise of the nation's healthcare bill.

24 Sep 2010

Bay Area nonprofit hospitals struggle with finances; Medicaid plan for neighborhood clinics in New Orleans approved

When Mountain View's El Camino Hospital last month announced plans to lay off about 140 workers due largely to a rise in nonpaying clients, the medical provider highlighted a debate over the financial health of the Bay Area's nonprofit hospitals.

24 Sep 2010

$Study finds high rate of C-sections in women suffering from pelvic fractures$

Study finds high rate of C-sections in women suffering from pelvic fractures

In research led by a Saint Louis University surgeon, investigators found that women who give birth after suffering pelvic fractures receive C-sections at more than double normal rates despite the fact that vaginal delivery after such injuries is possible. In addition, women reported lingering, yet often treatable, symptoms following their pelvic fracture injuries, from urinary complications to post-traumatic stress disorder.

24 Sep 2010

Avandia restricted by the FDA and EMEA

The U.S. Food and Drugs Administration (FDA) has restricted the use of the controversial diabetes drug Avandia (rosiglitazone) due to its propensity to increase cardiovascular disease risk.

24 Sep 2010

At six month anniversary, Obama touts benefits of health care law

Six rocky months after winning passage of the landmark health-care law, President Obama celebrated the half-year mark by holding a sunny backyard get-together in the Virginia suburbs with a sampling of Americans from across the country who he said are already benefitting.

24 Sep 2010

CNN, Telegraph examine global food security, food price volatility

In advance of Friday's special meeting, convened by the U.N. Food and Agriculture Organization (FAO), CNN examines the current state of food security around the world and the outlook over the next few years.

24 Sep 2010

BioSeek signs two-year agreement with Cellzome

Asterand plc, a leading provider of human tissue and human tissue-based research services to pharmaceutical and biotechnology companies engaged in drug discovery research, today announced that its subsidiary BioSeek, LLC, a pioneer in the application of predictive human biology to drug discovery, has signed a two-year agreement with Cellzome.

24 Sep 2010

A guide to Sept. 23: Health law's big day

According to this Kaiser Health News resource page, The national health reform that was signed into law exactly 6 months ago contained an ambitious timetable for changing elements of the health care system.

24 Sep 2010

Today's Opinions: The health law's 'Semi-Versary'

Six months after its enactment, there are two totally different stories to tell about the health-reform law. The public remains split on the law largely along traditional partisan lines

24 Sep 2010

Researchers report MALAT1 gene regulates pre-mRNA splicing in cancer

Researchers report this month that MALAT1, a long non-coding RNA that is implicated in certain cancers, regulates pre-mRNA splicing a critical step in the earliest stage of protein production. Their study appears in the journal Molecular Cell.

24 Sep 2010

Researchers to develop vitamin D producing fluorescent lamp for fat malabsorption syndromes

Boston University School of Medicine (BUSM) researchers have been awarded a Small Business Technology Transfer (STTR) phase 1 award to develop and test a newly designed fluorescent lamp that is capable of producing vitamin D in the skin.

24 Sep 2010

Abbott, Reata enter agreement to commercialize bardoxolone drug for CKD

Abbott and Reata Pharmaceuticals today announced that they have entered into a collaboration agreement to develop and commercialize bardoxolone methyl (bardoxolone), which is currently in late Phase 2 trials for the treatment of chronic kidney disease (CKD).

24 Sep 2010

Biothera receives SBIR award to evaluate therapeutic potential of Imprime PGG drug in pancreatic cancer

Biothera has received a National Cancer Institute SBIR award to evaluate the therapeutic potential of its drug candidate Imprime PGG in pancreatic cancer, the company announced today.

24 Sep 2010

Zalicus presents synergistic drug data at Targeted Cancer Therapies World Europe 2010 meeting

Zalicus Inc. presented data today on its discovery of novel synergistic drug combinations for the treatment of cancer at the Targeted Cancer Therapies World Europe 2010 meeting in Zurich on September 23, 2010.

24 Sep 2010

Research suggests race plays a factor in accident survival

African-American victims of motorcycle crashes were 1.5 times more likely to die from their injuries than similarly injured whites, even though many more of the African-American victims were wearing helmets at the time of injury, according to a new study by Johns Hopkins researchers.

23 Sep 2010

Cardialysis and Sticares InterACT announce strategic collaboration

Cardialysis and Sticares InterACT, both Contract Research Organizations (CROs) headquartered in The Netherlands, announced today that they have entered into a strategic collaboration to provide drug development consulting services in the field of cardiovascular and metabolic medicine. Both organizations have substantial experience and success in the execution of clinical research projects for pharmaceutical, biotechnology and medical device companies.

23 Sep 2010